MICHAEL KEENE: Open Payments
NPI 1376518134 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,919 in 120 payments from 19 companies in 2025. Trend: 2023 $2,843 · 2024 $4,110 · 2025 $2,919
Food & beverage: $2,763Education: $155
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $431 |
| UCB, Inc. | 10 | $334 |
| Janssen Biotech, Inc. | 13 | $278 |
| Galderma Laboratories, L.P. | 20 | $250 |
| Lilly USA, LLC | 6 | $217 |
| GENZYME CORPORATION | 6 | $202 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $201 |
| LEO Pharma Inc. | 7 | $194 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| Amgen Inc. | 4 | $109 |
Products named: Bimzelx, RINVOQ, DUPIXENT, TREMFYA, NEMLUVIO, ADBRY, SKYRIZI, ILUMYA.
Industry payments across NC — which companies pay providers there.
